alzhub.org
Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

Home › Research › Topics › antidiabetic-drug

antidiabetic-drug

6 studies tagged antidiabetic-drug, dated 2020-01-01 to 2024-08-21. Bibliography: BibTeX (.bib) · RIS (.ris)

Newest in this topic

  1. Repurposing antidiabetic drugs for Alzheimer's disease: A review of preclinical and clinical evidence and overcoming challenges 2024-08-21
  2. Repurposing and clinical attributes of antidiabetic drugs for the treatment of neurodegenerative disorders 2023-10-30
  3. Emerging Evidence for the Use of Antidiabetic Drugs, Glucagon-like Peptide 1 Receptor Agonists, for the Treatment of Alzheimer's Disease 2023-05-23

Studies

6 studies carry this tag.

Date range

2020 to 2024

Top journals

  • Dementia and geriatric cognitive disorders 1
  • European journal of pharmacology 1
  • Expert opinion on investigational drugs 1
  • Journal of Alzheimer's disease : JAD 1
  • Life sciences 1

6 journals in all.

Newest first, then by address. Each study has a usefulness score out of 100 (rubric version 4.0); tap a score to see what makes it up. Tags were assigned automatically from each study's title and summary. The same studies as a filter in the library.

  1. Repurposing antidiabetic drugs for Alzheimer's disease: A review of preclinical and clinical evidence and overcoming challenges

    ✓ Peer-reviewed alzhub usefulness score 41 out of 100. Life sciences 2024-08-21 Drug development

    Repurposing antidiabetic drugs for the treatment of Alzheimer's disease (AD) has emerged as a promising therapeutic strategy.

  2. Repurposing and clinical attributes of antidiabetic drugs for the treatment of neurodegenerative disorders

    ✓ Peer-reviewed alzhub usefulness score 40 out of 100. European journal of pharmacology 2023-10-30 Drug development

    The risk of neurodegeneration was found to be increased among people with type 2 diabetes mellitus (T2DM).

  3. Emerging Evidence for the Use of Antidiabetic Drugs, Glucagon-like Peptide 1 Receptor Agonists, for the Treatment of Alzheimer's Disease

    ✓ Peer-reviewed alzhub usefulness score 50 out of 100. TouchREVIEWS in endocrinology 2023-05-23 Drug development

    From an epidemiological and pathophysiological point of view, Alzheimer's disease (AD) and type 2 diabetes (T2DM) should be considered 'sister' diseases.

  4. New treatment approaches for Alzheimer's disease: preclinical studies and clinical trials centered on antidiabetic drugs

    ✓ Peer-reviewed alzhub usefulness score 40 out of 100. Expert opinion on investigational drugs 2022-01-02 Drug development

    Alzheimer's disease (AD) and type 2 diabetes mellitus (T2DM) represent two major chronic diseases that affect a large percentage of the population and share common pathogenetic mechanisms, including oxidative stress and inflammation.

  5. Antidiabetic Drugs in Alzheimer's Disease and Mild Cognitive Impairment: A Systematic Review

    ✓ Peer-reviewed alzhub usefulness score 72 out of 100. Dementia and geriatric cognitive disorders 2020-10-20 Drug development

    Intranasal insulin, pioglitazone, metformin, and liraglutide are promising drugs that could be useful in the treatment of AD.

  6. Dementia Diagnosis Is Associated with Changes in Antidiabetic Drug Prescription: An Open-Cohort Study of ∼130,000 Swedish Subjects over 14 Years

    ✓ Peer-reviewed alzhub usefulness score 60 out of 100. Journal of Alzheimer's disease : JAD 2020-01-01 Drug development

    Dementia patients had lower probability of receiving newer antidiabetic drugs, with simultaneous higher insulin dispensation compared to dementia-free subjects.

All topic tags with their study counts